CompletedNCT00187928
Topiramate for OCD
This study is completed in the United States. It is testing topiramate for OCD.
In United StatesOCDDrugA study involving a medication or substance.From 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT03150771
Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
This study is completed in the United States. It focuses on schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 64 Years
CompletedNCT04461119
Safety, Tolerability, and Efficacy of Evenamide in people with Chronic Schizophrenia
This study is completed in the United States and in India. It focuses on schizophrenia.
In United StatesSchizophreniaDrugOver 18 Years
CompletedNCT00399698
Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
This study is completed in the United States. It focuses on ADHD.
In United StatesADHD, BipolarityDrugFrom 4 Years to 14 Years
CompletedNCT02824666
D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
This study is completed in the United States. It focuses on Schizophrenia.
In United StatesSchizophreniaBehavioralFrom 18 Years to 50 Years
CompletedNCT03397134
Roluperidone for schizophrenia
This study is completed in the United States, in Bulgaria, in Poland, .... It is testing roluperidone for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT06836063
Ropanicant for Depression
This study is completed in the United States. It is testing ropanicant for Depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
CompletedNCT05683249
NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
This study is completed in the United States. It is testing NRCT-101SR for ADHD.
Remote / onlineADHDDrugOver 18 Years
TerminatedNCT06215144
NRCT-101SR in Pediatric Subjects With ADHD
This study was terminated in the United States. It is testing NRCT-101SR for ADHD.
Remote / onlineADHDDrugFrom 13 Years to 17 Years
CompletedNCT02489305
Potential Predictors of Relapse in people with Major Depressive Disorder (MDD)
This study is completed in the United States. It is testing potential Predictors of Relapse for depression.
In United StatesDepressionOtherFrom 18 Years to 64 Years
CompletedNCT01711021
Safety study of Safety & Efficacy of d-Amphetamine Transdermal System in ADHD
This study is completed in the United States. It is testing Safety & Efficacy of d-Amphetamine Transdermal System for ADHD.
Remote / onlineADHDBehavioralFrom 6 Years to 17 Years
TerminatedNCT02261519
Safety & Efficacy of NaBen® for schizophrenia
This study was terminated in the United States. It is testing safety & Efficacy of NaBen® for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 45 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.